Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Tin Mesoporphyrin IX: HO Assay Workflows
2026-09-15
A practical guide to using Tin Mesoporphyrin IX (chloride) as a direct pharmacological probe of heme oxygenase activity. The workflow connects enzyme inhibition with metabolic, ROS, and HBV-related assays while emphasizing controls, dose selection, and troubleshooting.
-
D-Lin-MC3-DMA: From LNP Design to Assays
2026-09-15
Dlin-MC3-DMA is an ionizable cationic liposome lipid for siRNA and mRNA delivery. This article explains how its chemistry, formulation variables, and machine-learning evidence can guide more informative LNP assay decisions.
-
TAK-242: A Translational Lens on TLR4 Biology
2026-09-14
TAK-242 (Resatorvid) offers translational researchers a selective way to interrogate TLR4 signaling, connect LPS-driven inflammation with neuroimmune outcomes, and distinguish receptor-proximal biology from downstream inflammatory effects. This thought-leadership guide integrates mechanistic rationale, evidence from an aged-rat cognitive model, practical protocol design, and strategic considerations for advancing neuroinflammation research.
-
Z-VAD-FMK in Resistant Lung Cancer Assays
2026-09-14
Z-VAD-FMK enables causal testing of caspase dependence in drug-resistant lung cancer models. This guide connects apoptosis inhibition with ferroptosis-aware assay design and insights from a 2025 EGFR-mutant lung adenocarcinoma study.
-
Cabazitaxel Workflow for Resistant Tumor Models
2026-09-13
Cabazitaxel (XRP6258, SKU B2157) provides a practical antiproliferative agent in cancer research focused on microtubule dynamics disruption, including taxane-resistant and P-glycoprotein-expressing models. It is intended for DMSO- or ethanol-based workflows, not direct aqueous preparation, and prepared solutions should be used promptly rather than stored long term.
-
Bestatin as a Chemical Genetics Tool for Jasmonate Signaling
2026-09-12
Zheng and colleagues showed that the aminopeptidase inhibitor bestatin can selectively activate jasmonate responses in tomato and Arabidopsis, while using its root-growth phenotype to isolate bestatin-resistant mutants. The study established a chemical-genetics framework that links pharmacological perturbation, transcriptomics, developmental phenotyping, and mutant analysis to identify previously unrecognized components of jasmonate signaling.
-
Dlin-MC3-DMA for LNP RNA Delivery
2026-09-12
Dlin-MC3-DMA supports high-potency siRNA and mRNA nanoparticle workflows, from hepatic gene silencing to cell-state-sensitive microglia assays. This practical guide connects formulation design, machine-learning-assisted screening, and troubleshooting for more reproducible RNA delivery experiments.
-
Fluorouracil and Wnt: A Translational Playbook
2026-09-11
Fluorouracil is more than a viability benchmark. This thought-leadership guide connects its thymidylate synthase mechanism with Wnt-driven tumor biology, immune context, experimental design, and translational decision-making in solid tumor research.
-
Nuclear mTORC1 Control Revealed by TerminaTOR
2026-09-11
The reference study introduces TerminaTOR, a genetically encodable inhibitor that can suppress mTORC1 selectively at defined subcellular locations. By separating lysosomal from nuclear mTORC1 activity, the authors show that nuclear mTORC1 regulates transcription of genes containing CCAAT motifs, extending mTORC1 biology beyond its canonical metabolic and translational functions.
-
Isorhamnetin N1358: Reliable Cell Assays
2026-09-10
This scenario-based guide explains how Isorhamnetin (SKU N1358) can improve experimental control in cell viability, proliferation, apoptosis, and oxidative stress workflows. It connects formulation, dose selection, controls, and mechanistic interpretation to published oocyte-maturation data and practical laboratory decision-making.
-
D-Lin-MC3-DMA: Ionizable Cationic Liposome
2026-09-10
Dlin-MC3-DMA is an ionizable cationic liposome lipid for LNP-based siRNA delivery and mRNA vaccine formulation. Reported product and peer-reviewed evidence connect MC3 with potent hepatic gene silencing, endosomal escape, and data-guided optimization of RNA delivery systems.
-
Dlin-MC3-DMA for Smarter RNA-LNP Design
2026-09-09
Dlin-MC3-DMA is an ionizable cationic liposome lipid for potent siRNA and mRNA delivery. This article explains how a 2025 machine-learning study shifts LNP development from carrier potency alone toward cell-state-aware assay design, with practical guidance for hepatic and microglial research.
-
BI 2536: PLK1 Inhibitor Workflow Guide
2026-09-09
BI 2536 combines subnanomolar PLK1 inhibition with practical readouts for mitotic arrest, checkpoint regulation, and apoptosis. This guide connects cell-based dose–response experiments with mechanistic MCC-disassembly assays and tumor xenograft interpretation.
-
WSP-5 for Live-Cell H2S Imaging
2026-09-08
WSP-5 converts hydrogen sulfide reactivity into a rapid, turn-on fluorescence signal for live-cell experiments, donor-release studies, and disease modeling. This guide translates diabetic cardiomyopathy findings into practical assay design, controls, optimization steps, and troubleshooting decisions.
-
RNA Clean and Concentrator Kit for IRES Assays
2026-09-07
The RNA Clean and Concentrator Kit supports controlled RNA purification from enzymatic reactions, with particular value for IRES-focused antiviral assays. This guide explains how cleanup chemistry influences mechanistic interpretation, assay controls, and reproducibility beyond routine spin-column use.